b12 injections where Vitamin Injection Sites: All You Need to Know Vitamin B12 IM Injectable at

Retatrutide, the triple agonist targeting GLP-1, GIP, and glucagon receptors, shows approximately 24% weight loss in phase 2 trials

In the event of vitamin B12 deficiency, digestive disorders are common (nausea, diarrhoea, constipation)

BPC-157 stable gastric pentadecapeptide: novel therapy for wound healing and tissue repair Life Sciences Seiwerth S et al

Retatrutide dosing protocol Retatrutide uses a different titration approach, reflecting its greater potency and triple-receptor activity: Weeks 1-4: 1 mg once weekly (starting dose) Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Week 17 onward: 8-12 mg once weekly (maintenance dose) Some trial protocols use a slightly modified schedule, escalating every four weeks with dose increases of approximately double at each step

The data strongly suggests yes